GlassScriptPhysician profile
Andre S Godet
NPI 1649211194
$5,436.41
in general payments reported to CMS, 2019-2025
28 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $229 · 2021: $623 · 2022: $1,288 · 2023: $1,575 · 2024: $629 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907 · Travel and Lodging: $694 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.31 |
| Travel and Lodging | $694.46 |
| Education | $171.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $865.64 | 2019-2025 | Lithoclast, Lithovue, Moses 550 Dfl |
| Procept Biorobotics Corporation | $860.90 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $805.53 | 2019-2025 | Xtandi |
| Dornier Medtech America, INC | $613.65 | 2022 | |
| Janssen Biotech, INC. | $545.55 | 2019-2024 | Erleada |
| Sumitomo Pharma America, INC. | $254.42 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $239.72 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $198.88 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Pfizer INC. | $175.03 | 2019-2025 | |
| Fujifilm Healthcare Americas Corporation | $153.05 | 2021 | |
| Penumbra, INC. | $102.65 | 2023 | Ruby Coil |
| Janssen Scientific Affairs, LLC | $85.85 | 2024 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $81.29 | 2022 | |
| Tersera Therapeutics LLC | $55.30 | 2022 | |
| 180 Medical, INC. | $53.45 | 2024 | Gentlecath |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $51.40 | 2021-2022 | |
| Urovant Sciences INC | $46.80 | 2022 | |
| Coloplast Corp | $41.15 | 2024 | |
| Novartis Pharmaceuticals Corporation | $38.75 | 2025 | |
| Progenics Pharmaceuticals, INC. | $26.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.67 | 2022 | |
| Urogen Pharma, INC. | $23.30 | 2022 | |
| Olympus America INC. | $21.79 | 2025 | Itind System |
| Allergan, INC. | $17.74 | 2021 | |
| Travere Therapeutics, INC. | $15.64 | 2019-2021 | |
| Becton, Dickinson and Company | $13.19 | 2019 | |
| Endo Pharmaceuticals INC. | $12.82 | 2021 | |
| Merck Sharp & Dohme LLC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Godet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.